Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens.

Arif JM, Dresler C, Clapper ML, Gairola CG, Srinivasan C, Lubet RA, Gupta RC.

Chem Res Toxicol. 2006 Feb;19(2):295-9.

PMID:
16485906
2.

Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.

Badawi AF, Stern SJ, Lang NP, Kadlubar FF.

Prog Clin Biol Res. 1996;395:109-40. Review.

PMID:
8895986
3.

DNA adducts as a measure of lung cancer risk in humans exposed to polycyclic aromatic hydrocarbons.

Kriek E, Van Schooten FJ, Hillebrand MJ, Van Leeuwen FE, Den Engelse L, De Looff AJ, Dijkmans AP.

Environ Health Perspect. 1993 Mar;99:71-5. Review.

4.

Polycyclic aromatic hydrocarbon (PAH) exposure and DNA adduct semi-quantitation in archived human tissues.

Pratt MM, John K, MacLean AB, Afework S, Phillips DH, Poirier MC.

Int J Environ Res Public Health. 2011 Jul;8(7):2675-91. doi: 10.3390/ijerph8072675. Epub 2011 Jun 29. Review.

5.

Biological monitoring and biochemical effect monitoring of exposure to polycyclic aromatic hydrocarbons.

Angerer J, Mannschreck C, Gündel J.

Int Arch Occup Environ Health. 1997;70(6):365-77. Review.

PMID:
9439982
6.

Human DNA adduct measurements: state of the art.

Poirier MC, Weston A.

Environ Health Perspect. 1996 Oct;104 Suppl 5:883-93. Review.

7.

Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.

Randerath K, Liehr JG, Gladek A, Randerath E.

IARC Sci Publ. 1989;(96):189-205. Review.

PMID:
2509347
8.

[Metabolic polymorphisms and biomarkers of exposition to polycyclic aromatic hydrocarbons (PAH)].

Szczeklik J.

Przegl Lek. 2005;62(12):1542-5. Review. Polish.

PMID:
16786792
9.

Biomonitoring of tobacco smoke carcinogenicity by dosimetry of DNA adducts and genotyping and phenotyping of biotransformational enzymes: a review on polycyclic aromatic hydrocarbons.

Besaratinia A, Kleinjans JC, Van Schooten FJ.

Biomarkers. 2002 May-Jun;7(3):209-29. Review. Erratum in: Biomarkers. 2005 Mar-Jun;10(2-3):218. Besarati Nia, A [corrected to [Besaratinia, A].

PMID:
12141065
10.

Molecular dosimetry of DNA damage induced by polycyclic aromatic hydrocarbons; relevance for exposure monitoring and risk assessment.

Baan RA, Steenwinkel MJ, van den Berg PT, Roggeband R, van Delft JH.

Hum Exp Toxicol. 1994 Dec;13(12):880-7. Review.

PMID:
7718309
11.
12.

Lung carcinogenesis by tobacco smoke.

Hecht SS.

Int J Cancer. 2012 Dec 15;131(12):2724-32. doi: 10.1002/ijc.27816. Epub 2012 Oct 3. Review.

13.
14.

[Cigarette smoking and lung cancer-elucidating an enigma].

Ciornea L, Miron L, Ghiorghiu S.

Rev Med Chir Soc Med Nat Iasi. 2001 Jan-Mar;105(1):49-53. Review. Romanian.

PMID:
12092158
15.

Tobacco smoke carcinogens and breast cancer.

Hecht SS.

Environ Mol Mutagen. 2002;39(2-3):119-26. Review.

PMID:
11921179
16.

Linking the generation of DNA adducts to lung cancer.

Ceppi M, Munnia A, Cellai F, Bruzzone M, Peluso MEM.

Toxicology. 2017 Sep 1;390:160-166. doi: 10.1016/j.tox.2017.09.011. Epub 2017 Sep 18. Review.

PMID:
28928033
17.

Dynamic conformational heterogeneities of carcinogen-DNA adducts and their mutagenic relevance.

Cho BP.

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2004;22(2):57-90. Review.

PMID:
16291518
18.

Tobacco and cancer: epidemiology and the laboratory.

Vineis P, Caporaso N.

Environ Health Perspect. 1995 Feb;103(2):156-60. Review.

19.

Oral Cell DNA Adducts as Potential Biomarkers for Lung Cancer Susceptibility in Cigarette Smokers.

Hecht SS.

Chem Res Toxicol. 2017 Jan 17;30(1):367-375. doi: 10.1021/acs.chemrestox.6b00372. Epub 2016 Dec 1. Review.

20.

Alcohol, Aldehydes, Adducts and Airways.

Sapkota M, Wyatt TA.

Biomolecules. 2015 Nov 5;5(4):2987-3008. doi: 10.3390/biom5042987. Review.

Supplemental Content

Support Center